Search

152 Result(s)
Sort by

Our Expectations

Our Expectations

We are committed to exemplary ethical and professional conduct both within the company and from our suppliers.
Access to Care platform

Access to Care platform

Discover how Boehringer Ingelheim is addressing health equity and healthcare access in Central and Eastern Europe through the "Access to Care" platform. Learn about the Legal Toolkit designed for patient advocates and the impact of our initiatives in the
history movie

history movie

Learn more about Boehringer Ingelheim's history of more than 130 years, from the beginning in 1885 to today. We share documents and insights from our history, our business areas and our research and development activities across the decades.
Partnering

Partnering

We are convinced that diversity and exchange in science give birth to innovations. For this reason, partnerships are an important component of our innovation strategy.
Improving Access to Healthcare

Improving Access to Healthcare

According to the UN Sustainable Development Goals, nearly half of the world's population lacks access to basic health care.
Mental Health

Mental Health

Boehringer Ingelheim has a range of different compounds in development for Central Nervous System (CNS) diseases, some in advanced clinical phases.
Code of Conduct

Code of Conduct

Our Code of Conduct sets the ethical standards that guides all our business activities. It´s about all of us. Each individual plays a vital role in bringing the Code of Conduct to live.
Animal Health

Animal Health

Discover how Boehringer Ingelheim aims to ensure your companion pet gets the same level healthcare as people whether it be a normal house pet or horse.
Making sustainable medicines through eco-design

Making sustainable medicines through eco-design

Our goal is to minimize the environmental footprint of our medicines through integration of eco-design and green chemistry across the entire lifecycle
Drug discovery Boehringer Ingelheim

Drug discovery Boehringer Ingelheim

Every day, scientists at Boehringer Ingelheim embark on a journey. It is a journey that can take up to 15 years and requires significant investment. Only a tiny proportion of these journeys are successful.